Does GANCICLOVIR Cause Malignant neoplasm progression? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Malignant neoplasm progression have been filed in association with GANCICLOVIR (Ganciclovir). This represents 0.4% of all adverse event reports for GANCICLOVIR.
20
Reports of Malignant neoplasm progression with GANCICLOVIR
0.4%
of all GANCICLOVIR reports
14
Deaths
8
Hospitalizations
How Dangerous Is Malignant neoplasm progression From GANCICLOVIR?
Of the 20 reports, 14 (70.0%) resulted in death, 8 (40.0%) required hospitalization, and 1 (5.0%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GANCICLOVIR. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does GANCICLOVIR Cause?
Off label use (1,104)
Drug ineffective (924)
Cytomegalovirus infection (668)
Drug resistance (594)
Pancytopenia (403)
Product use in unapproved indication (400)
Neutropenia (396)
Cytomegalovirus infection reactivation (301)
Cytomegalovirus viraemia (294)
Product use issue (279)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which GANCICLOVIR Alternatives Have Lower Malignant neoplasm progression Risk?
GANCICLOVIR vs GANIRELIX
GANCICLOVIR vs GATIFLOXACIN
GANCICLOVIR vs GEFITINIB
GANCICLOVIR vs GELATIN
GANCICLOVIR vs GEMCITABINE